Ketepatan Penggunaan Antipsikotik pada Pasien Skizofrenia di Rumah Sakit Jiwa Dr. Radjiman Wediodiningrat

Dhani Eko Wahyu Syah Putra, Eko Denny Wahyudi, Agung Permata, Nanang Ardianto

Abstract


Schizophrenia is a disorder that affects psychotics and causes the typical thought process distortions that psychotics experience, such as the feeling that they are under the control of outside forces, perceptual abnormalities, and sometimes bizarre, abnormal delusions that interact with real or actual situations. The purpose of this study was to determine the pattern of antipsychotic drug use and the accuracy of drugs, patients, doses, and frequency of drug use in schizophrenia patients at Dr. Radjiman Wediodiningrat Mental Hospital (RSJ) Lawang, Malang. This study uses a quantitative non-experimental method with a descriptive approach. The research data were collected retrospectively. The data used in this study are medical record data of patients with a diagnosis of schizophrenia. There were 80 schizophrenia patients in February-March 2023 who met the inclusion and exclusion criteria. The results of the study were more male patients 53 (66.25%) and aged 31-40 as many as 30 (37.5%). The most common type of schizophrenia is hebephrenic as many as 53 (66.35%) patients, patients with atypical therapy 51 (63.75%). The level of accuracy of drugs, patients, doses and frequencies obtained 100%. The conclusion of this study is 100% correct patients, medication, dose, and frequency in schizophrenia patients.

Keywords


Accurac; Medication use; Antipsychotics; Schizophrenia patients

Full Text:

PDF

References


S. Zahnia And D. Wulan Sumekar, “Kajian Epidemiologis Skizofrenia,” Majority, Vol. 5, No. 5, Pp. 160–166, 2016, [Online]. Available: Http://Juke.Kedokteran.Unila.Ac.Id/Index.Php/Majority/Article/View/904/812

A. P. Tantan Hadiansyah, “Kecemasan Keluarga Dalam Merawat Klien Skizofrenia,” Vol. 7, No. 1, Pp. 25–29, 2020.

F. Fitri, I. Saleh, And T. Theodorus, “Polimorfisme Gen Drd2 Rs1799732 (-141c) Terhadap Terapi Aripiprazole Pada Pasien Skizofrenia,” J. Sains Dan Kesehat., Vol. 4, No. 2, Pp. 214–221, 2022, Doi: 10.25026/Jsk.V4i2.783.

S. Novitayani, “Penyebab Skizofrenia Pada Pasien Rawat Jalan Di Aceh,” Idea Nurs. J., Vol. 8, No. 3, Pp. 1–7, 2017.

N. K. Wijiani Yanti And D. I Andayani, “Evaluasi Tepat Pasien, Tepat Obat, Dan Tepat Dosis Penggunaan Antipsikotik Pasien Skizofrenia Di Rumah Sakit Jiwa Provinsi Ntb,” J. Insa. Farm. Indones., Vol. 4, No. 1, Pp. 111–120, 2021, Doi: 10.36387/Jifi.V4i1.658.

A. R. Fadilla And R. M. Puspitasari, “Evaluasi Ketepatan Penggunaan Antipsikotik Pada Pasien Skizofrenia Rawat Inap. Program Studi Farmasi. Fakultas Farmasi. Institut Sains Dan Teknologi Nasional.,” Sainstech Farma, Vol. 9, No. 1, Pp. 41–46, 2016.

R. Paramitha, E. Endang, And M. Kartika, “Analisis Rasionalitas Penggunaan Antipsikotik Pada Pasien Skizofrenia Di Instalasi Rawat Inap Rsjd Atma Husada Mahakam Samarinda Tahun 2016 Rationality Of Antipsicotic Use In Hospitalized Skizofrenia Patients In Rsjd Atma Husada Mahakam Samarinda 2016,” J. Farm. Indones., Vol. 15, No. 1, Pp. 19–28, 2018.

F. Anas Dwi Yulinar Buhar, Arman And Atmah A. Gobel, “Faktor Risiko Kejadian Skizofrenia Di Wilayah Kerja Puskesmas Malangke Barat Kec. Malangke Barat Kab. Luwu Utara Tahun 2022,” J. Muslim Community Heal., Vol. 4, No. 2, Pp. 183–192, 2022.

A. Permata, A. Fitri, M. R. Abdullah, And N. Salmasfattah, “Penilaian Tingkat Kecemasan Pasien Program Rujuk Balik Di Fasilitas Kesehatan Tingkat Pertama Kota Malang,” Vol. 16, No. 2, Pp. 45–51, 2023.

A. Wahyudi And A. I. Fibriana, “Faktor Resiko Terjadinya Skizofrenia (Studi Kasus Di Wilayah Kerja Puskesmas Pati Ii),” Public Heal. Perspect. J., Vol. 1, No. 1, Pp. 1–12, 2016.

P. Gianiodis, S. C. Ellis, And E. Secchi, “Penggunaan Antipsikotik Pada Pasien Skizofrenia,” Perspect. Supplier Innov. Theor. Concepts Empir. Insights Open Innov. Integr. Suppliers, Vol. 7, No. 11, 2022.

G. P. Girsang, M. G. Tarigan, And E. A. Pakpahan, “Karakteristik Penelitian Skizofrenia,” J. Kedokt. Methodist, Vol. 13, No. 1, Pp. 58–66, 2020, [Online]. Available: Https://Ejurnal.Methodist.Ac.Id/Index.Php/Jkm/Article/View/1334

A. Fitriani, “Psikoterapi Suportif Pada Penderita Skizofrenia Hebefrenik,” Proyeksi, Vol. 13, No. 2, P. 123, 2020, Doi: 10.30659/Jp.13.2.123-133.

Et Al Putri, “Profil Penggunaan Antipsikotik Dan Antiansietas Pada Pasien Skizofrenia Rawat Inap Di Rumah Sakit Jiwa Mutiara Sukma Provinsi Ntb Tahun 2021,” J. Village Local Community, Vol. 1, No. 1, Pp. 59–80, 2022.

H. Dania, I. N. Faridah, K. F. Rahmah, R. Abdulah, M. I. Barliana, And D. A. Perwitasari, “Hubungan Pemberian Terapi Antipsikotik Terhadap Kejadian Efek Samping Sindrom Ekstrapiramidal Pada Pasien Rawat Jalan Di Salah Satu Rumah Sakit Di Bantul, Yogyakarta,” Indones. J. Clin. Pharm., Vol. 8, No. 1, 2019, Doi: 10.15416/Ijcp.2019.8.1.19.

I. D. Ratnasari, “Analisis Drug Related Problems Penggunaan Antipsikotik Pada Penderita Schizophrenia Dewasa Di Rumah Sakit Jiwa X Surabaya Ike Desy Ratnasari,” J. Ilm. Mhs. Univ. Surabaya, Vol. 7, No. 1, Pp. 721–735, 2018, [Online]. Available: Http://Www.Journal.Ubaya.Ac.Id/Index.Php/Jimus/Article/View/1192




DOI: https://doi.org/10.37311/ijpe.v3i3.23235

Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 Dhani Eko Wahyu Syah Putra, Eko Denny Wahyudi, Agung Permata, Nanang Ardianto

Creative Commons License
Indonesian Journal of Pharmaceutical Education is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.